We are thrilled to be the first company to offer a safe, effective and innovative microneedling system in Canada.
Addison, TX (PRWEB)
August 30, 2017
Bellus Medical, a leader in medical aesthetics products and devices, is pleased to announce that Canadians will now be able to enjoy the skin-enhancing benefits of the innovative products Bellus Medical offers. This includes the SkinPen® Precision microneedling device, Skinfuse™ post-microneedling protocol, and coming in October, Allumera®, a breakthrough photodynamic topical cosmetic cream.
SkinPen® Precision is Bellus Medical’s flagship product, and now with Health Canada’s Medical Device license Number 99476, Bellus will offer the complete SkinPen® microneedling system, including the Skinfuse™ treatment kit, to treat Melasma, acne, and surgical scars in Canada. The SkinPen® microneedling system raises the standard in technology and is backed by the highest medical device standards available to practices and their patients. SkinPen® is the only device on the market exclusively designed and engineered with the following safety features:
- Patent pending sterile, single use microneedle cartridge that houses a reciprocating mechanism typically enclosed in the microneedling pen, ensuring a long-term reliability of the SkinPen® Precision device.
- Ingress protection to prevent any blood, fluid or serum present during the procedure from penetrating into the pen.
- 14 stainless steel medical grade needles that create 1633 micro-injuries per second for increased efficiency.
- Bio-Sheath, designed specifically for SkinPen®, helps protect patients from potential cross-contamination, ensuring fluids generated during the procedure…